Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients - Concepedia

Concepedia

Publication | Open Access

Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients

DOI Full Paper Access

41

Citations

35

References

2021

Year

Xi Chen, Liangjie Fang, Yan‐Ping Zhu, Zhang Bao, Qing Wang, Rong Liu, Wenjia Sun, Haiwei Du, Jing Lin, Bing Yu,

Cancer Immunology Immunotherapy

Cancer ImmunosurveillanceCheckpoint InhibitorsMedicineImmunologyPathologyCancer GenomicsBronchial NeoplasmImmune Checkpoint InhibitorCancer GeneticsImmunotherapyOncologyClinical ResponseLung Cancer

References

	Year	Citations

Page 1

Page 1